Cite
Nino A, Okuda I, Wilson TH, et al. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017;doi: 10.1111/jdi.12749.
Nino, A., Okuda, I., Wilson, T. H., Yue, L., Nakajima, H., Tsuboi, M., Carr, M. C., & Seino, Y. (2017). Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Journal of diabetes investigation, . https://doi.org/10.1111/jdi.12749
Nino, Antonio, et al. "Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study." Journal of diabetes investigation vol. (2017). doi: https://doi.org/10.1111/jdi.12749
Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16. PMID: 28921915; PMCID: PMC5934244.
Copy
Download .nbib